Who is this course for?
Physicians and prescribers seeking advanced knowledge of psychedelic medicine and psychedelic-assisted therapy.
An advanced psychedelic-assisted therapy course for physicians and prescribers covering psychedelic medicine, patient suitability, safety, pharmacology, therapeutic applications, and regulatory frameworks in Canada, Australia, and the United States. The program includes self-paced video lessons, live Q&A sessions, and
ATMA’s Physicians & Prescribers Psychedelic-assisted Therapy Course is designed for practitioners seeking advanced knowledge of psychedelic medicine. It examines contemporary and Indigenous histories, current research, therapeutic applications, pharmacology, drug interactions, adverse events, and evolving regulatory frameworks across Canada, Australia, and the United States. The course focuses on assessing patient suitability, inclusion and exclusion criteria, dosing principles, safety, collaborative care, and access through Canada’s Special Access Program. It also addresses inclusion and access challenges affecting marginalized populations, including LGBTQIA+ and BIPOC communities. The program includes 9 modules of pre-recorded lectures, monthly live Q&A sessions, lifetime access to learning materials and industry updates, an online practitioner community, and 11 optional live online self-care sessions with recordings. The listed course duration is 20 hours, with an additional 11 hours for the optional self-care sessions.
Physicians and prescribers seeking advanced knowledge of psychedelic medicine and psychedelic-assisted therapy.
ATMA Journey Centers is an Alberta-based Canadian pioneer in psychedelic-assisted therapy, operating clinically supervised locations across Canada while offering comprehensive psychedelic-assisted therapy training programs (ATMA CENA) covering psilocybin, MDMA, and ketamine for healthcare professionals. With 740+ training alumni and 800+ community members, ATMA also operates a clinic network partnership program and Phase II psilocybin clinical trials with Health Canada approval.
View all Atma Journey coursesPhysicians and prescribers seeking advanced knowledge of psychedelic medicine and psychedelic-assisted therapy.
Format: Live Classes. Time commitment: 11 hours.
The listed price is $1,897. Confirm the latest tuition, fees, and payment options on the provider website.
Accreditation note: CME. Confirm credential eligibility directly with the provider before enrolling.
This active course does not have a listed upcoming cohort date yet. Check the provider website for current schedule details.
The current listing status is Active. Use the provider website for the latest enrollment status.
By IPI
Shares course skills and categories
The IPI Online Psychedelic-Assisted Therapy Training is a year-long program designed for therapists, physicians, nurses, and other allied mental healthcare professionals who want to expand their skill set in psychedelic-assisted therapy.
Source lists: 140 hours
Delivery: Online
By Fluence
Shares course skills and categories
Explore fundamentals of psilocybin clinical research, pharmacology, therapeutic models, and ethical considerations surrounding psilocybin in clinical treatment.
Self-paced access
Source lists: 7 hours
Delivery: Self-paced
By Psychedelic Support
Shares course skills and categories
Learn about the pharmacology, mechanism and effects of ketamine and how this substance is being used therapeutically in clinical research and elsewhere.
Self-paced access
Source lists: 5 hours
Delivery: Self-paced
No medicine self-experience listed